{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T08:26:57Z","timestamp":1766824017654,"version":"3.48.0"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_rir-2025-0027_s_006\">\n                    <jats:title>Background and Objectives<\/jats:title>\n                    <jats:p>Certain genetic traits increase the likelihood of developing rheumatoid arthritis (RA); nevertheless, the association between RA and polymorphisms in the CD209 gene is ambiguous. This study sought to investigate the correlation between RA susceptibility and the CD209 single nucleotide polymorphisms rs4804803 (AG) and rs735239 (AG) within the Egyptian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_rir-2025-0027_s_007\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This case-control study was conducted between January and October 2024 and included 108 participants. Of these, 54 patients were diagnosed with RA according to the 2010 classification criteria of the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). Two CD209 promoter regions rs4804803 (-336A\/G) and rs735239 (-871A\/G) were genotyped for single nucleotide polymorphisms (SNPs) using multiplex polymerase chain reaction (PCR) and double amplification refractory system (dARMS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_rir-2025-0027_s_008\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with RA showed significantly higher frequencies of the CD209 rs4804803 SNP in the AG (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.036) and GG (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.006) genotypes compared to controls. Under the dominant paradigm, those with CD209 rs4804803 genotypes (AG+GG) had an elevated risk of RA (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003). In recessive inheritance model, RA patients had a greater frequency of the rs4804803 GG polymorphism than controls (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.017). Additionally, relative to the A allele, the rs4804803 G allele raised the risk of RA (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.001). No significant difference was observed between the two groups in the distribution of rs735239 genotypes. However, RA patients carrying the rs4804803 AG or GG genotypes exhibited significantly higher rates of morning stiffness (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.001) and elevated CRP levels (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.009).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_rir-2025-0027_s_009\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This work highlights the significant role of the CD209 rs4804803 polymorphism, particularly the G allele, in the elevated susceptibility to RA among Egyptians.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/rir-2025-0027","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T08:23:15Z","timestamp":1766823795000},"page":"220-231","source":"Crossref","is-referenced-by-count":0,"title":["CD209 gene polymorphism and its clinical correlation with susceptibility to rheumatoid arthritis among Egyptian patients: A case-control study"],"prefix":"10.1515","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5661-850X","authenticated-orcid":false,"given":"Rasha Mokhtar","family":"Elnagar","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Faculty of Medicine, Mansoura University , Mansoura , Egypt"},{"name":"Department of Basic Medical Sciences, College of Medicine, AlMaarefa University , Diriyah , , Riyadh , Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira M.","family":"Sultan","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Faculty of Medicine, Mansoura University , Mansoura , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Elshaer","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Faculty of Medicine, Mansoura University , Mansoura , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa A.","family":"Awad","sequence":"additional","affiliation":[{"name":"Department of Physical medicine, Rheumatology and Rehabilitation, Faculty of medicine, Mansoura University , Mansoura , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia Kamal","family":"Nassar","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Faculty of Medicine, Mansoura University , Mansoura , Egypt"},{"name":"Department of Basic Medical Sciences, Faculty of Medicine, Ibn Sina University for Medical Sciences , Amman , Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"2025122708231026684_j_rir-2025-0027_ref_001","doi-asserted-by":"crossref","unstructured":"Ridgley LA, Anderson AE, Pratt AG. What are the dominant cytokines in early rheumatoid arthritis? Curr Opin Rheumatol. 2018;30:207\u2013214.","DOI":"10.1097\/BOR.0000000000000470"},{"key":"2025122708231026684_j_rir-2025-0027_ref_002","doi-asserted-by":"crossref","unstructured":"Mohammed HA, Ahmed ZA, Alrawi AAO. DC-SIGN Receptor Level in Rheumatoid Arthritis Patients in Baghdad; Serological study. Baghdad Sci J. 2022;19:1212\u20131218.","DOI":"10.21123\/bsj.2022.6559"},{"key":"2025122708231026684_j_rir-2025-0027_ref_003","doi-asserted-by":"crossref","unstructured":"Marzaioli V, Canavan M, Floudas A, et al. CD209\/CD14+ Dendritic Cells Characterization in Rheumatoid and Psoriatic Arthritis Patients: Activation, Synovial Infiltration, and Therapeutic Targeting. Front Immunol. 2022;12:722349.","DOI":"10.3389\/fimmu.2021.722349"},{"key":"2025122708231026684_j_rir-2025-0027_ref_004","doi-asserted-by":"crossref","unstructured":"Petrelli F, Mariani FM, Alunno A, et al. Pathogenesis of rheumatoid arthritis: one year in review 2022. Clin Exp Rheumatol. 2022;40:475\u2013482.","DOI":"10.55563\/clinexprheumatol\/l9lyen"},{"key":"2025122708231026684_j_rir-2025-0027_ref_005","doi-asserted-by":"crossref","unstructured":"Lenz TL, Deutsch AJ, Han B, et al. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet. 2015;47:1085\u20131090.","DOI":"10.1038\/ng.3379"},{"key":"2025122708231026684_j_rir-2025-0027_ref_006","doi-asserted-by":"crossref","unstructured":"Stegmann F, Lepenies B. Myeloid C-type lectin receptors in host-pathogen interactions and glycan-based targeting. Curr Opin Chem Biol. 2024;82:102521.","DOI":"10.1016\/j.cbpa.2024.102521"},{"key":"2025122708231026684_j_rir-2025-0027_ref_007","doi-asserted-by":"crossref","unstructured":"Wehr P, Purvis H, Law SC, et al. Dendritic cells, T cells and their interaction in rheumatoid arthritis. Clin Exp Immunol. 2019;196:12\u201327.","DOI":"10.1111\/cei.13256"},{"key":"2025122708231026684_j_rir-2025-0027_ref_008","doi-asserted-by":"crossref","unstructured":"Afifi RA, Kamal D, Sayed RE, et al. CD209\u2013336A\/G promotor polymorphism and its clinical associations in sickle cell disease Egyptian Pediatric patients. Hematol Oncol Stem Cell Ther. 2018;11:75\u201381.","DOI":"10.1016\/j.hemonc.2017.09.002"},{"key":"2025122708231026684_j_rir-2025-0027_ref_009","doi-asserted-by":"crossref","unstructured":"Yang ZS, Huang SW, Wang WH, et al. Identification of Important N-Linked Glycosylation Sites in the Hemagglutinin Protein and Their Functional Impact on DC-SIGN Mediated Avian Influenza H5N1 Infection. Int J Mol Sci. 2021;22:743.","DOI":"10.3390\/ijms22020743"},{"key":"2025122708231026684_j_rir-2025-0027_ref_010","doi-asserted-by":"crossref","unstructured":"Choi B, Suh CH, Kim HA, et al. The Correlation of CD206, CD209, and Disease Severity in Beh\u00e7et\u2018s Disease with Arthritis. Mediators Inflamm. 2017;2017:7539529.","DOI":"10.1155\/2017\/7539529"},{"key":"2025122708231026684_j_rir-2025-0027_ref_011","doi-asserted-by":"crossref","unstructured":"Tu J, Huang W, Zhang W, et al. A Tale of Two Immune Cells in Rheumatoid Arthritis: The Crosstalk Between Macrophages and T Cells in the Synovium. Front Immunol. 2021;12:655477.","DOI":"10.3389\/fimmu.2021.655477"},{"key":"2025122708231026684_j_rir-2025-0027_ref_012","doi-asserted-by":"crossref","unstructured":"Herrero R, Pineda JA, Rivero-Juarez A, et al. Common haplotypes in CD209 promoter and susceptibility to HIV-1 infection in intravenous drug users. Infect Genet Evol. 2016;45:20\u201325.","DOI":"10.1016\/j.meegid.2016.08.014"},{"key":"2025122708231026684_j_rir-2025-0027_ref_013","doi-asserted-by":"crossref","unstructured":"Zupin L, Polesello V, Alberi G, et al. CD209 promoter polymorphisms associate with HCV infection and pegylated-interferon plus ribavirin treatment response. Mol Immunol. 2016;76:49\u201354.","DOI":"10.1016\/j.molimm.2016.06.009"},{"key":"2025122708231026684_j_rir-2025-0027_ref_014","doi-asserted-by":"crossref","unstructured":"Korzeniowska A, Bryl E. Infectious agents in the pathogenesis of autoimmune rheumatic diseases. Transl Res. 2025;276:39\u201345.","DOI":"10.1016\/j.trsl.2024.12.004"},{"key":"2025122708231026684_j_rir-2025-0027_ref_015","doi-asserted-by":"crossref","unstructured":"da Silva RC, Cunha Tavares Nde A, Moura R, et al. DC-SIGN polymorphisms are associated to type 1 diabetes mellitus. Immunobiology. 2014;219:859\u2013865.","DOI":"10.1016\/j.imbio.2014.07.011"},{"key":"2025122708231026684_j_rir-2025-0027_ref_016","doi-asserted-by":"crossref","unstructured":"Naderi M, Hashemi M, Taheri M, et al. CD209 promoter -336 A\/G (rs4804803) polymorphism is associated with susceptibility to pulmonary tuberculosis in Zahedan, southeast Iran. J Microbiol Immunol Infect. 2014;47:171\u2013175.","DOI":"10.1016\/j.jmii.2013.03.013"},{"key":"2025122708231026684_j_rir-2025-0027_ref_017","doi-asserted-by":"crossref","unstructured":"Chan HC, Wang SC, Lin CH, et al. A novel CD209 polymorphism is associated with rheumatoid arthritis patients in Taiwan. J Clin Lab Anal. 2021 ;35:e23751.","DOI":"10.1002\/jcla.23751"},{"key":"2025122708231026684_j_rir-2025-0027_ref_018","doi-asserted-by":"crossref","unstructured":"Tan Y, Jian H, Zhang R, et al. Applying amplification refractory mutation system technique to detecting cell-free fetal DNA for single-gene disorders purpose. Front Genet. 2023;14:1071406.","DOI":"10.3389\/fgene.2023.1071406"},{"key":"2025122708231026684_j_rir-2025-0027_ref_019","doi-asserted-by":"crossref","unstructured":"Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263\u2013265.","DOI":"10.1093\/bioinformatics\/bth457"},{"key":"2025122708231026684_j_rir-2025-0027_ref_020","doi-asserted-by":"crossref","unstructured":"Hou J, Gao W. IL-27 regulates autophagy in rheumatoid arthritis fibroblast-like synoviocytes via STAT3 signaling. Immunobiology. 2022;227:152241.","DOI":"10.1016\/j.imbio.2022.152241"},{"key":"2025122708231026684_j_rir-2025-0027_ref_021","doi-asserted-by":"crossref","unstructured":"C\u00e1liz R, Canet LM, Lupia\u00f1ez CB, et al. Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis. PLoS One. 2013;8:e72732.","DOI":"10.1371\/journal.pone.0072732"},{"key":"2025122708231026684_j_rir-2025-0027_ref_022","doi-asserted-by":"crossref","unstructured":"G\u00f3mez LM, Martin JJ, Anaya JM. CD209 (DC-SIGN) G-336A Polymorphism is Associated With Rheumatoid Arthritis: P32\/O8. J Clin Rheumatol. 2006;12:S10.","DOI":"10.1097\/01.rhu.0000217162.59707.cc"},{"key":"2025122708231026684_j_rir-2025-0027_ref_023","doi-asserted-by":"crossref","unstructured":"Dieguez-Gonzalez R, Akar S, Calaza M, et al. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA. J Rheumatol. 2009;36:1590\u20131595.","DOI":"10.3899\/jrheum.090022"},{"key":"2025122708231026684_j_rir-2025-0027_ref_024","doi-asserted-by":"crossref","unstructured":"Gheita TA, Raafat HA, El-Bakry SA, et al. Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance. Rheumatol Int. 2023;43:667\u2013676.","DOI":"10.1007\/s00296-022-05258-2"},{"key":"2025122708231026684_j_rir-2025-0027_ref_025","doi-asserted-by":"crossref","unstructured":"Hussain W, Noorwali A, Janoudi N, et al. From Symptoms to Diagnosis: An Observational Study of the Journey of Rheumatoid Arthritis Patients in Saudi Arabia. Oman Med J. 2016;31:29\u201334.","DOI":"10.5001\/omj.2016.06"}],"container-title":["Rheumatology and Immunology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/rir-2025-0027\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/rir-2025-0027\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T08:23:20Z","timestamp":1766823800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/rir-2025-0027\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,27]]},"published-print":{"date-parts":[[2025,12,27]]}},"alternative-id":["10.1515\/rir-2025-0027"],"URL":"https:\/\/doi.org\/10.1515\/rir-2025-0027","relation":{},"ISSN":["2719-4523"],"issn-type":[{"value":"2719-4523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}